A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT01120561 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT01120561
- Sponsor
- Genentech, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
- Start date
- 2010-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.